Disruptive technologies, developing drugs, and building companies to treat disease

ALL WELCOME
Prof. Harvey Lodish will share some of his experiences as a researcher who has been active in biotechnology industry for over 35 years. He has started 7 companies including Genzyme and Millennium, and most recently Rubius, a company that is developing engineered red cells as a vehicle for introducing into the human body novel therapeutics that function for several months.

Date: 30 September 2015, 14:00 (Wednesday, -1st week, Michaelmas 2015)
Venue:
NDM Building
Headington OX3 7FZ
See location on maps.ox

Details: Basement Seminar Room
Speaker: Prof. Harvey Lodish (Whitehead Institute)
Organising department: Ludwig Institute for Cancer Research, Oxford Branch
Organisers: Mary Muers (Oxford Ludwig Institute, NDM Experimental Medicine), Alexandra Ward (University of Oxford, Oxford Ludwig Institute, NDM Experimental Medicine)
Organiser contact email address: alexandra.ward@ludwig.ox.ac.uk
Host: Prof Xin Lu (Ludwig Cancer Research, Oxford Branch)
Part of: Ludwig Institute Seminar Series
Topics:
Booking required?: Not required
Audience: Members of the University only
Editor: Mary Muers